Funded Tech Companies

Gennao Bio

Wondering who invested in Gennao Bio? OrbiMed, Logos Capital and Surveyor Capital joined the equity holders in this innovative biopharmaceutical company.

Company Overview

Company Name
Gennao Bio
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
Undisclosed
New York, NY 10001
USA
Phone
Undisclosed
Website
Email Address
Not Recorded

Company Background Information

Overview
Gennao Bio is a privately held genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.
Profile
Gennao Bio LinkedIn Company Profile
Social Media
Gennao Bio Company Twitter Account
Company News
Gennao Bio News
Facebook
Gennao Bio on Facebook
YouTube
Gennao Bio on YouTube
Last Transaction
5/11/2021

Financing History

Date
Type
Amount
Venture Equity
$40,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Stephen Squinto
  Stephen Squinto LinkedIn Profile  Stephen Squinto Twitter Account  Stephen Squinto News  Stephen Squinto on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Genmo | Genneve

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary